51st week of 2009 patent applcation highlights part 34 |
Patent application number | Title | Published |
20090311120 | GEAR PUMP - An intended purpose of this invention is to realize a gear pump suitable for delivery of high-pressure and high-viscosity fluids by using helical gears | 2009-12-17 |
20090311121 | MICROWAVE FABRICATION OF AIRFOIL TIPS - A method of producing a metallic component includes: providing a body made of a first alloy; providing a preform comprising a metallic powder made of a second alloy and formed in the shape of an extension of the body; and heating the preform with microwave energy to sinter the metallic powder together and to bond the preform to the body. The method may be used to make new components as well as to repair or modify existing components. | 2009-12-17 |
20090311122 | POWDER FORGED MEMBER, POWDER MIXTURE FOR POWDER FORGING, METHOD FOR PRODUCING POWDER FORGED MEMBER, AND FRACTURE SPLIT TYPE CONNECTING ROD USING THE SAME - A member produced by powder forging which retains machinability and improved fatigue strength without having an increased hardness and can retain self conformability after fracture splitting; a powder mixture for powder forging; a process for producing a member by powder forging; and a fracture splitting connecting rod obtained from the member produced by powder forging. The member produced by powder forging is one obtained by preforming a powder mixture, subsequently sintering the preform, and forging the resultant sintered preform at a high temperature. The free-copper proportion in the sintered preform at the time when the forging is started is 10% or lower, and the member obtained through the forging has a composition containing, in terms of mass %, 0.2-0.4% C, 3-5% Cu, and up to 0.4% Mn (excluding 0), the remainder being iron and incidental impurities, and has a ferrite content of 40-90%. | 2009-12-17 |
20090311123 | METHOD FOR PRODUCING METAL ALLOY AND INTERMETALLIC PRODUCTS - This invention relates to a method for producing alloy and intermetallic powders. Particularly to a method for the production of titanium based alloy and intermetallic powders. A first metal and a second metal oxide powder are mixed with a controlled metal/metal oxide molar ratio. This mixture is heated, becomes self propagating and leads to formation of a mixture of alloy liquid and a oxide solid. Pressure is applied to separate the phases and upon cooling produces a metallic solid. FIG. | 2009-12-17 |
20090311124 | METHODS FOR SINTERING BODIES OF EARTH-BORING TOOLS AND STRUCTURES FORMED DURING THE SAME - A first green or brown object is sintered while being supported by a second green or brown object in a furnace, and a body of an earth-boring tool is formed from the first object. An object is sectioned to form first and second structures, and the first structure is sintered within a furnace while it is supported by (e.g., resting on) the second structure. A layer of powder material is provided on a green or brown object, another green or brown object is rested on the powder material over the first green or brown object, and the first and second green or brown objects are sintered with the powder material therebetween. Intermediate structures formed during fabrication of a body of an earth-boring tool include a layer of powder between a green or brown tool body precursor and a green or brown structure supporting the green or brown tool body. | 2009-12-17 |
20090311125 | HOT-WORKING STEEL EXCELLENT IN MACHINABILITY AND IMPACT VALUE - Provided is a hot-working steel excellent in machinability and impact value comprising, in mass %, C: 0.06 to 0.85%, Si: 0.01 to 1.5%, Mn: 0.05 to 2.0%, P: 0.005 to 0.2%, S: 0.001 to 0.35%, and Al: 0.06 to 1.0% and N: 0.016% or less, in contents satisfying Al×N×10 | 2009-12-17 |
20090311126 | LEAD-FREE FREE-CUTTING PHOSPHOROUS BRASS ALLOY AND ITS MANUFACTURING METHOD - Considering the solid solubility of P in the matrix of copper will be decreased rapidly with the temperature decrease and form the brittle intermetallic compounds Cu | 2009-12-17 |
20090311127 | LEAD-FREE FREE-CUTTING MAGNESIUM BRASS ALLOY AND ITS MANUFACTURING METHOD - A lead-free free-cutting magnesium brass alloy comprises 56.0 to 64.0 wt % Cu, 0.6 to 2.5 wt % Mg, 0.15 to 0.4 wt % P and other elements 0.002 to 0.9 wt % which comprise at least two elements selected from the group consisting of Al, Si, Sb, Sn, Re, Ti and B and the balance being Zn and unavoidable impurities. The process for producing such alloy is also proposed. The invented alloy is excellent in cuttability, castability, hot and cold workability, corrosion resistance, mechanical properties and weldability and particularly applicable in spare parts, forging and castings which need cutting, grinding and electroplating process. The cost of necessary metal materials of the invented alloy is lower than lead-free free-cutting bismuth and antimony brass alloy and is equivalent to lead-contained brass alloy. | 2009-12-17 |
20090311128 | COPPER ALLOY SHEETS FOR ELECTRICAL/ELECTRONIC PART - A shear plane ratio is reduced by a dislocation density in which a value obtained by dividing the half-value width β of the intensity of diffraction of {311} plane in the surface of a Cu—Fe—P alloy sheet, by its peak height H, is 0.015 or more. | 2009-12-17 |
20090311129 | ABRASION RESISTANT SINTERED COPPER BASE CU-NI-SN ALLOY AND BEARING MADE FROM THE SAME - A Cu—Ni—Sn copper-based sintered alloy has a composition including 10 to 40% by mass of Ni, 5 to 25% by mass of Si, and the remainder containing Cu and inevitable impurities, and if necessary, 0.1 to 0.9% by mass of P, 1 to 10% by mass of C, 0.3 to 6% by mass of calcium fluoride or 0.3 to 6% by mass of molybdenum disulfide. In the structure of the alloy, a phase of a composition containing Cu | 2009-12-17 |
20090311130 | TIN-FREE, LEAD-FREE FREE-CUTTING MAGNESIUM BRASS ALLOY AND ITS MANUFACTURING METHOD - A tin-free lead-free free-cutting magnesium brass alloy comprises 56.0 to 64.0 wt % Cu, 0.6 to 2.5 wt % Mg, 0.15 to 0.4 wt % P and other elements 0.002 to 0.9 wt % which comprise at least two elements selected from the group consisting of Al, Si, Sb, Re, Ti and B and the balance being Zn with unavoidable impurities. The process for producing such alloy is also proposed. The invented alloy is excellent in cuttability, castability, hot and cold workability, corrosion resistance, mechanical properties and weldability and particularly applicable in spare parts, forging and casting which need cutting and grinding process. The cost of necessary metal materials of the invented alloy is lower than lead-free free-cutting bismuth and antimony brass alloy and is equivalent to lead-contained brass alloy. | 2009-12-17 |
20090311131 | STERILIZING METHOD AND STERILIZING APPARATUS FOR RETORTED PRODUCTS - A sterilizing apparatus for retorted products is provided, which can transfer the retorted products unidirectionally to and from a retort and which can heat and sterilize the retorted products homogeneously for a short time, while sliding a carriage carrying the retorted products reciprocally in the retort. The rotating motions of a rotating drive source ( | 2009-12-17 |
20090311132 | METHODS FOR MAKING A SUPPORTED GRAFT - A method for forming a self-expanding stent-graft, including coupling a shape memory member to a polymer cladding to form a polymer clad member, winding a length of the polymer clad member about a mandrel so that adjacent windings include regions of polymer cladding that overlap, heating the wound polymer clad member to join and seal the overlapping regions to one another, manipulating the stent-graft from a first diameter to a second diameter smaller than the first diameter, and loading the stent-graft into a restraining sheath, wherein the restraining sheath prevents the stent-graft from reverting to the first diameter. | 2009-12-17 |
20090311133 | DRUG-DELIVERY PUMPS AND METHODS OF MANUFACTURE - Embodiments of method of manufacturing an implantable pump, including providing an upper layer comprising a dome structure for housing a drug chamber and a cannula in fluid communication with the drug chamber, providing a middle deflection layer adjacent the drug chamber, providing a bottom layer comprising electrolysis electrodes, and bonding the upper layer, middle deflection layer, and bottom layer to form the pump. | 2009-12-17 |
20090311134 | STERILANTS AND STERILIZATION METHOD FOR ASEPTIC FILLING - The present invention provides an aqueous solution of a sterilant of peracetic acid series for use in aseptic filling comprised predominantly of hydrogen peroxide, peracetic acid and water wherein a pH of the aqueous solution is 2˜4, a ratio of the concentration of hydrogen peroxide/the concentration of peracetic acid is 0.7 or less, and the concentration of peracetic acid is 500˜3000 ppm as well as a sterilization method wherein the sterilant thereof is used. The sterilant of peracetic acid series exhibits an excellent sterilizing effect even at an extremely low concentration of peracetic acid and so is economically advantageous. What is more, washing of the sterilant with sterile water after sterilization of a container is attained by injecting sterile water even for a short period of time to such level that the sterilized container can be filled with foods and drinks, so that the sterilant is remarkable in economical value and working efficiency. The sterilization method is carried out by heating the sterilant of peracetic acid series and/or a container for foods and the like or the interior surface thereof at 60° C. or higher to obtain more effective sterilizing effect and can be used in a recycling system, so far as a ratio of the concentration of hydrogen peroxide/the concentration of peracetic acid be maintained. | 2009-12-17 |
20090311135 | APPARATUS AND METHOD FOR DRYING INSTRUMENTS USING SUPERHEATED STEAM - An apparatus and method for drying instruments using superheated steam is disclosed. The apparatus comprises a chamber for receiving the instruments, a distribution means for distributing superheated steam within the chamber and an exhaust means for purging vaporized moisture from the chamber. The chamber has at least one inlet port which is connected to the distribution means. The method comprises sterilizing the instruments using saturated steam generated by the steam generation means and drying the instruments using superheated steam generated by the steam generation means to vaporize moisture within the chamber and purging the vaporized moisture from the chamber using the exhaust means. | 2009-12-17 |
20090311136 | Enzymatic antibacterial cleaner having high pH stability - The present invention is directed to an antibacterial cleaning composition comprising: (a) an enzyme in an amount effective to promote cleaning; (b) viable microorganisms in an amount effective to degrade and promote the degradation of organic materials; (c) a surfactant; and (d) an aqueous carrier; said cleaning composition maintaining at least 95% enzymatic activity at a pH range of from about 5.5 to about 13.5. | 2009-12-17 |
20090311137 | ATOMIZER USING ELECTROLYZED LIQUID AND METHOD THEREFOR - An apparatus and method are provided for generating an electrochemically activated liquid that is rendered at least partially aerosol. | 2009-12-17 |
20090311138 | SANITIZATION OF AIRCRAFT OR VEHICLE CABIN - A method of sanitizing a passenger cabin includes excluding people from the passenger cabin and substantially sealing the passenger cabin such that air inside the passenger cabin is prevented from exiting the passenger cabin. An ozone enriched atmosphere is created inside the passenger cabin by generating ozone and directing the ozone into the passenger cabin to increase an ozone concentration of the atmosphere inside the passenger cabin to at least a minimum concentration. The ozone enriched atmosphere is circulated through the passenger cabin and air circulation system thereof for a sanitation period calculated to be sufficient for sanitation. The ozone concentration of the atmosphere inside the passenger cabin is then reduced to a level safe for human occupation. | 2009-12-17 |
20090311139 | Device for Analyzing Constituents of a Sample - The invention relates to a device for analysing constituents of a sample. Said device comprises sensor molecules that are deposited on one surface of a carrier, which optionally bond with the constituents to be analysed. The aim of the invention is to reliably detect even negligible quantities of sample constituents to be analysed and to obtain good results from said analysis. To achieve this, the carrier consists of a centrifuge head that can be inserted into a sample container, leaving a radial annular gap exposed. The peripheral surface of the centrifuge head forms the surface that is to be provided with the sensor molecules. | 2009-12-17 |
20090311140 | Combined unit of humidity indicator and desiccant pack - A combined unit of a humidity indicator and a desiccant pack is provided in which the humidity indicator (I) has one end portion bonded to one end portion of the desiccant pack (D) and can pivot around between a standby position (Ia) in which the indicator (I) overlaps one face of the desiccant pack (D) and an in-use position (Ib) in which it overhangs outside from one end edge (De) of the desiccant pack (D)), with the pivot center in the bonding portion or the vicinity thereof. This enables the humidity indicator to overlap the desiccant pack in the standby position when it is in an unused state, and after being enclosed within a packaging bag the humidity indicator and the desiccant pack can be kept as far away from each other as possible within the packaging bag, thus enabling detection of the humidity of the interior of the bag to be carried out precisely and appropriately. | 2009-12-17 |
20090311141 | IMMUNOCHROMATOGRAPHIC STRIP FOR USE IN IMMUNOASSAY AND KIT COMPRISING THE SAME - The present invention relates to an immunochromatographic strip and a kit comprising the same. The immunochromatographic strip according to the present invention is characterized in that it comprises a) an adhesive plastic backing, b) a sample pad receiving a liquid sample to be analyzed, which is attached on the surface of the top portion of the adhesive plastic backing, a conjugate pad coupled to the sample pad, which contains a conjugate specifically binding to an analyte in the liquid sample from the sample pad, d) a signal detection pad coupled to the conjugate pad, which comprises a signal detection zone to detect the presence of the analyte in the liquid sample and a control zone to confirm whether the liquid sample chromatographically migrates regardless of the presence of the analyte, and e) an absorbent pad positioned downstream of the signal detection pad, which absorbs the liquid sample after the completion of the signal detection reaction and comprises a porous backing and an absorbent dispersed, adsorbed, or coated into the pores of the porous backing. It is more preferable that the absorbent pad further comprises a film layer attached on the top portion of the porous backing. It is most preferable that the film layer attached on the top portion of the porous backing is a porous membrane. The absorbent pad having the above-described structure efficiently absorbs the liquid sample after the completion of the signal detection reaction. As a result, the chromatographic flow is improved, test errors caused by the backflow of liquid sample are reduced, background clearance is improved, and the result of signal detection is consistently maintained. More significantly, with the help of the absorption ability improved by the absorbent which is dispersed into the porous backing, more preferably adsorbed, or coated onto fibers of the porous backing, the immunochromatographic strip and kit comprising the same absorb moisture in air quickly and sufficiently. Thus, in addition to improved performance, there is no need to package the strip or the kit with an additional absorbent bag in a pouch, which makes the packaging process simple, thereby improving the speed of automatic packaging process. | 2009-12-17 |
20090311142 | DEVICE FOR RAPID DETERMINATION OF DISEASE-ASSOCIATED THIOL COMPOUNDS - Disclosed is a single-use disposable article for determining the concentration of thiol compounds in a sample of fluid, and a description of how to make and use the article. | 2009-12-17 |
20090311143 | Micro reactor having micro flow-guiding blocks - A micro reactor having micro flow-guiding blocks includes a first gas flow channel, a second gas flow channel and a catalytic converter. There are several flow-guiding portions disposed on the first gas flow channel. Each flow-guiding portion has micro flow-guiding blocks, flow-impact recesses, and catalytic portions. The function of the micro flow-guiding block is to guide a flowing direction of the flow toward the catalytic portion on the flow-impact recess in order to increase a possibility of contacting and chemical reaction with the catalytic portion. So, guiding the flow direction toward the catalytic portion can increase the overall reaction efficiency. More turbulence is generated to obtain a better mixing. Plus, its structure is simple. | 2009-12-17 |
20090311144 | DISCOLORATION INDICATORS FOR CHECKING LIFE SPAN OF DESULFURIZATION DISORBENT, AND DESULFURIZATION REACTOR AND DESULFURIZATION SYSTEM COMPRISING THE SAME - This invention relates to a discoloration indicator for checking the life span of a desulfurization adsorbent, and a desulfurization reactor and a desulfurization system including the same, and specifically, to a discoloration indicator for checking the life span of a desulfurization adsorbent able to effectively adsorb and remove organic sulfur compounds from fossil fuels, including natural gas or LPG containing the organic sulfur compound, and to a desulfurization reactor and a desulfurization system including the same. This invention makes it possible to remove the organic sulfur compound using the desulfurization adsorbent and to check the replacement time of the adsorbent with the naked eye or using an electrical signal, and thus may be applied to the treatment of natural gas or LPG requiring desulfurization, and also to hydrogen generators for home fuel cell generation systems or distributed fuel cell generation systems requiring that devices be simple, or requiring unmanned operation. | 2009-12-17 |
20090311145 | REACTION CHAMBER STRUCTURAL PARTS WITH THERMAL SPRAY CERAMIC COATING AND METHOD FOR FORMING THE CERAMIC COATING THEREOF - In a reaction chamber for manufacturing semiconductor devices, flat displays, solar panels, a thermal spray ceramic coating with special geometric patterns is provided on structural parts in the reaction chamber. The geometric patterns of the ceramic coating are designed according to operating conditions in the reaction chamber, such as the energy source and the plasma producing gases being used, the intended plasma distribution and subsequent reactions in the reaction chamber, and compositions of the ceramic coating. To form the ceramic coating with special geometric patterns, a special masking process is adopted, and, after the forming of the ceramic coating with desired geometric patterns, a post grit blasting treatment is conducted to obtain a desired surface coarseness for the ceramic coating. | 2009-12-17 |
20090311146 | EXHAUST GAS TREATING APPARATUS - An exhaust gas treating apparatus includes an upstream honeycomb structure and a downstream honeycomb structure each provided along an exhaust gas flowing direction of the exhaust gas treating apparatus. Each of the plurality of honeycomb structures includes at least one honeycomb unit includes zeolite, an inorganic binder, and walls. A first ratio of weight of zeolite ion-exchanged with at least one of Cu, Mn, Ag, and V in the downstream honeycomb structure is greater than a first ratio of weight of zeolite ion-exchanged with at least one of Cu, Mn, Ag, and V in the upstream honeycomb structure. A second ratio of weight of zeolite ion-exchanged with at least one of Fe, Ti, and Co in the upstream honeycomb structure is greater than a second ratio of weight of the zeolite ion-exchanged with at least one of Fe, Ti, and Co in the downstream honeycomb structure. | 2009-12-17 |
20090311147 | System for storing an additive and injecting it into the exhaust gases of an engine - Process for storing an additive and injecting it into the exhaust gases of an engine and comprising two tanks for storing the additive and one pump for supplying the additive from these tanks to an injection line, these two tanks being in parallel and each being connected to the pump by a branch of the supply line, each of these branches being equipped with a non-return valve and these two valves being calibrated so that the valve located in the branch coming from the first tank ( | 2009-12-17 |
20090311148 | Heated Volatile Dispensing Device With Use-Up Indicator - Heated volatile dispensers are disclosed that are provided with automated use-up indicators. The indicators are associated with a porous substrate. A migrateable dye is covered by meltable material adjacent the substrate. Heating of a substrate such as a slab impregnated with an insect repellent both causes the insect repellent to dispense and melts the covering. The dye then migrates to a visible surface of the substrate to indicate a degree of use. The extent of migration, and the patterns formed on the visible surface by the migrating dye, indicate the extent to which the volatile air treatment chemical has been dispensed. | 2009-12-17 |
20090311149 | UV Sanitizer for Tethered and Untethered Mouthguards - A portable, battery-powered UV sanitizer kills germs and bacteria on the mouthpieces of tethered mouthguards of a wide variety of tether sizes and configurations and on the mouthpieces of untethered mouthguards. It doubles as a protective case when not in antimicrobial use. It includes a dishwasher safe detachable tray. It may be used with other dental appliances. | 2009-12-17 |
20090311150 | CHEMICAL REACTOR INCLUDING HEAT EXCHANGERS - The present invention discloses to a chemical reactor with high heat efficiency and small volume, the chemical reaction of the present invention comprises a first unit for performing heat exchange of exothermic reaction products with exothermic reaction raw material fed for exothermic reaction; a second unit including a plate assembly for exothermic reactions and a plate assembly for endothermic reactions; and a third unit for performing heat exchange of endothermic reaction products with endothermic reaction raw material fed for endothermic reactions, the exothermic reaction raw material discharged from the first unit is fed into the plate assembly for exothermic reactions in the second unit and used in the exothermic reactions, the exothermic reaction products are fed into the first unit to pre-heat the exothermic reaction raw material, the endothermic reaction raw material discharged from the third unit is fed into the plate assembly for endothermic reactions in the second unit and used in the endothermic reactions, the endothermic reaction products are fed into the third unit to pre-heat the endothermic reaction raw material, and the first unit, the second unit and the third unit are laminately disposed. | 2009-12-17 |
20090311151 | System for On-Line Spalling of a Coker - Coker heater operation is improved by on-line spalling of coker heater pipes. In one embodiment an off-line pipe is added to the on-line coker heater pipes. When an on-line pipe is to be spalled, flow is diverted to the offline pipe allowing for full operation of the coker heater. In another embodiment, a thermal transfer resistant zone plate is movably mounted in the radiant section of the coker heater. By moving the zone plate from an operating position to a spalling position and adjusting the temperature of the plurality of burners, the temperature of the pipes in the zone of the heater radiant section to be spalled can be lowered, while the temperature in the remaining zones of the heater radiant section are fully operational. | 2009-12-17 |
20090311152 | ACTIVATED VAPOR TREATMENT FOR NEUTRALIZING WARFARE AGENTS - Hydrogen peroxide is vaporized ( | 2009-12-17 |
20090311153 | Sulfate Process - A sulfate process for producing titania from a titaniferous material (such as an iron-containing titaniferous material such as ilmenite) is disclosed. The process includes digestion and/or leach steps that form a process solution that includes an acidic solution of titanyl sulfate (TiOSO4) and iron sulfate (FeSO4) from the solid titaniferous material. The process also includes hydrolysis and other steps that form titania from the titanyl sulfate in the process solution. The process is characterised by a ferric ion treatment step of treating the process solution and lowering the concentration of ferric ions from the process solution. | 2009-12-17 |
20090311154 | Extraction process for reactive metal oxides - The present invention relates to a zero-waste process for extraction of alumina from different types of bauxite ores and red mud residues and of titanium dioxide from ilmenite. Iron oxide is first reduced to metallic iron above the melting point of C-saturated cast iron alloy which yields a high-C iron alloy and an Al and Ti metal oxide rich slag which is then treated with alkali carbonate to form alkali aluminates and titanates. The alkali aluminates are separated by water leaching from which the hydroxide of alumina is precipitated by bubbling CO | 2009-12-17 |
20090311155 | CATALYST FOR OXIDATION OF METAL MERCURY - A catalyst is provided having higher mercury oxidation performance than a conventional catalyst without increasing catalyst quantity or enhancing SO | 2009-12-17 |
20090311156 | REMOVAL OF CONTAMINANTS FROM GAS STREAMS - A process for the removal of contaminants from a gas stream is disclosed. A gas stream is contacted with a chlorine-containing compound to form a mixed gas stream. The mixed gas stream is then contacted with a sorbent in a sorption zone to produce a product gas stream and a sulfur laden sorbent, wherein the sorbent comprises zinc and a promoter metal. | 2009-12-17 |
20090311157 | NUCLEOPHILIC RADIOFLUORINATION USING MICROFABRICATED DEVICES - A microscale solution for conducting [ | 2009-12-17 |
20090311158 | Sol-Gel Process for the Preparation of Nanocrystalline CETI2O6 Powder - The present invention provides an improved sol-gel process for the preparation of nanocrystalline CeTi | 2009-12-17 |
20090311159 | FUMED SILICA FOR USE AS AUXILIARY IN PHARMACEUTICAL AND COSMETIC COMPOSITIONS - Fumed silica for use as auxiliary substance in pharmaceutical and cosmetic compositions, which has—a BET surface area of 90 to 400 m | 2009-12-17 |
20090311160 | Silicon single crystal and method of producing the same - The present invention provides a silicon single crystal comprising a seed crystal, a narrowed portion whose diameter decreases, and at its lower end, a neck portion, wherein in a front projection view, the contour of the narrowed portion is located inside the straight line connecting the contour of the lower end of the seed crystal to the contour of the upper end of the neck portion, and the contour of the neck portion is made to be a tangent at the lower end of the narrowed portion. At this time, the length L of the narrowed portion in a pulling direction and the difference d between the radius of the seed crystal and the radius of the narrowed portion relative to the diameter W of the seed crystal is appropriately adjusted and further the contour of the narrowed portion is desirably formed with any one of parabolas, circular arcs and elliptic arcs. Configuring the contour of the narrowed portion in this manner makes it possible to remove dislocations from the neck portion with a high success rate, shorten a pulling time of the silicon single crystal and improve the dislocation free ratio. | 2009-12-17 |
20090311161 | METHOD AND CONFIGURATION FOR MELTING SILICON - A process for melting silicon, in which silicon bodies ( | 2009-12-17 |
20090311162 | ALUMINUM NITRIDE SINTERED BODY AND MANUFACTURING METHOD THEREOF - An aluminum nitride sintered body in which the ratio of a peak area S2 of a diffraction peak at 2θ=34° or more and 35° or less corresponding to an aluminum oxynitride phase to a peak area S1 of a diffraction peak of an aluminum nitride crystal face [100] in X-ray diffraction, i.e. S2/S1, is 0.01 or more and 0.3 or less, and the spin concentration at a magnetic field between 336 mT and 342 mT as measured by an electron spin resonance method is 1×10 | 2009-12-17 |
20090311163 | DRUG, DRUG GUIDANCE SYSTEM, MAGNETIC DETECTION SYSTEM, AND DRUG DESIGN METHOD - It is intended to provide a drug delivery system which makes it possible to solve the existing technical problems and is easily usable in practice. A drug, which comprises an organic compound or an inorganic compound and has been magnetized by modifying a side chain and/or crosslinking side chains, is induced by a magnetic force into target tissues or an affected part. | 2009-12-17 |
20090311164 | METHOD FOR PRODUCING A STABLE OXIDIZING BIOCIDE - The invention relates to a production method for producing stable chloramine. The method allows for the production of stable chloramine with the use of concentrated chlorine source and concentrated amine source and agitation during production. The method produces a chloramine that has a pH of at least 5 with a most preferred pH of at least 7 or greater. | 2009-12-17 |
20090311165 | Generation of carbon monoxide for testing sensors and detectors - A method and apparatus for generating carbon monoxide and in particular a device for testing carbon monoxide detectors which utilises the method and apparatus for generating carbon monoxide. A layer of Activated Carbon Cloth is heated so that it produces small quantities of carbon monoxide. The Activated Carbon Cloth may be provided in a removable cassette. | 2009-12-17 |
20090311166 | Continuous Process for the Production of Nanostructures Including Nanotubes - The present invention provides methods for uniform growth of nanostructures such as nanotubes (e.g., carbon nanotubes) on the surface of a substrate, wherein the long axes of the nanostructures may be substantially aligned. The nanostructures may be further processed for use in various applications, such as composite materials. For example, a set of aligned nanostructures may be formed and transferred, either in bulk or to another surface, to another material to enhance the properties of the material. In some cases, the nanostructures may enhance the mechanical properties of a material, for example, providing mechanical reinforcement at an interface between two materials or plies. In some cases, the nanostructures may enhance thermal and/or electronic properties of a material. The present invention also provides systems and methods for growth of nanostructures, including batch processes and continuous processes. | 2009-12-17 |
20090311167 | METHOD AND APPARATUS FOR SYNTHESIZING FILAMENTARY STRUCTURES - Method and apparatus for producing filamentary structures. The structures include single-walled nanotubes. The method includes combusting hydrocarbon fuel and oxygen to establish a non-sooting flame and providing an unsupported catalyst to synthesize the filamentary structure in a post-flame region of the flame. Residence time is selected to favor filamentary structure growth. | 2009-12-17 |
20090311168 | System and method for manufacturing carbon nanotubes - A system and method for manufacturing carbon nanotubes via epitaxial growth from a source of supersaturated carbon solution is disclosed, whereby selection of the diameter, length, and chirality of single-walled or multi-walled nanotubes is enabled. | 2009-12-17 |
20090311169 | COMBUSTION SYNTHESIS AND DOPING OF OXIDE SEMICONDUCTORS - The present invention relates to a method for producing inorganic oxide particles from a precursor material or mixture under combustion synthesis and compositions thereof. The combustion synthesis method is low-cost, low tech, and energy efficient. The combustion synthesized inorganic oxide particles of the method are smaller and exhibits a lower band gap than commercially available specimen of the same chemical composition. | 2009-12-17 |
20090311170 | PROCESS FOR REDUCING GANGUE BUILD-UP IN THE REACTOR DURING THE CHLORIDE PROCESS THAT USES RECYCLED ORE - The disclosure provides a process for recycling ore in the chloride process, without the build-up of silica-containing gangue in the chlorination reactor. | 2009-12-17 |
20090311171 | Hydrogen Storage in a Combined MxAlH6/M'y(NH2)z System and Methods of Making and Using the Same - As a promising clean fuel for vehicles, hydrogen can be used for propulsion, either directly or in fuel cells. Hydrogen storage compositions having high storage capacity, good dehydrogenation kinetics, and hydrogen release and uptake reactions which are reversible are disclosed and described. Generally a hydrogen storage composition of a metal aluminum hexahydride and a metal amide can be used. A combined system (Li | 2009-12-17 |
20090311172 | Massage cream and massaging method using the same - The present invention relates to a massage cream which contains 5.0 Bq to 300.0 Bq of powders of one or more radioactive materials per 1 g of base materials. Furthermore in the massage cream the radioactive materials include 4.0 Bq to 240.0 Bq of thorium. Moreover in the massage cream the radioactive materials further include 1.0 Bq to 60.0 Bq of uranium. With the massage cream, medical effects can be given to the body of a person. | 2009-12-17 |
20090311173 | METHOD AND DEVICE FOR RADIOTHERAPY - A radiotherapy method, comprising positioning a predetermined amount of a radionuclide selected from the group consisting of Radium-223, Radium-224, Radon-219 and Radon-220, in proximity to and/or within a tumor of a subject, for a predetermined time period. The predetermined amount and the predetermined time period are selected sufficient for the radionuclide to administering a predetermined therapeutic dose of decay chain nuclei and alpha particles into the tumor. | 2009-12-17 |
20090311174 | Method For Treating Cancer - The present invention relates to methods, kits, compositions and uses thereof for treating cancer. In particular, the present invention relates to methods, kits, compositions and uses thereof for the treatment of metastatic cancer, the treatment of angiogenesis associated with metastatic cancer, inhibiting formation of vasculature associated with metastatic cancer, killing pericytes associated with metastatic cancer and killing cancer cells contiguous with tumour capillaries associated with metastatic cancer, comprising a killing agent conjugated to a protein, and wherein said killing agent conjugated to said protein binds to at least one cell associated with the metastatic cancer. | 2009-12-17 |
20090311175 | METHODS FOR TREATING THYROID CANCER - The invention provides methods for enhancing iodine absorption in a thyroid in a subject and treating thyroid cancer by administering to the subject a composition which includes a multi-kinase inhibitor. Furthermore, the invention provides methods for improving a medical diagnostic procedure based on radioactive iodine in a subject by administering to the subject a composition comprising a multi-kinase inhibitor. | 2009-12-17 |
20090311176 | 2-Arylpyrazolo[L,5-Alpha] Pyrimidin-3-YL Acetamide Derivatives as Ligands for Translocator Protein (18 Kda) - The invention provides compounds of formula (I) radiolabelled with | 2009-12-17 |
20090311177 | Radiolabelling Methods - The invention relates to radiodiagnostic and radiotherapeutic agents, including biologically active vectors labelled with radionuclides. It further relates to methods and reagents labelling a vector such as a peptide comprising reaction of a compound of formula (I) with a compound of formula (II): R*-L2-N | 2009-12-17 |
20090311178 | PYRROLINIDIUM DERIVATIVES AS M3 MUSCARINIC RECEPTORS - Compounds of formula (I) in salt or zwitterionic form, wherein R | 2009-12-17 |
20090311179 | Selective Targeting of Apoptotic Cells - The invention relates to a method of selectively targeting an active agent (or agent capable of becoming an active agent) to apoptotic cells in a vertebrate, comprising administering to said vertebrate a system comprising an arsenoxide (or arsenoxide equivalent) compound and said agent, wherein said system selectively targets apoptotic cells. | 2009-12-17 |
20090311180 | Protein Isoforms and Uses Thereof - A method for screening for or diagnosis or prognosis of a neurological disorder in a subject, for determining the stage or severity of such a neurological disorder in a subject, for identifying a subject at risk of developing such a neurological disorder, or for monitoring the effect of therapy administered to a subject having such a neurological disorder, said method comprising: (a) analyzing a test sample of body fluid or tissue from the subject said sample comprising at least one Protein Isoform selected from the Protein Isoform Nos 1-6 listed in Table 1; and (b) comparing the abundance of said Protein Isoform(s) in the test sample with the abundance of said Protein Isoform(s) in a test sample from one or more persons free from neurological disorder, or with a previously determined reference range for that Protein Isoform in subjects free from neurological disorder, wherein a diagnosis of or a positive result in screening for or a prognosis of a more advanced condition of said neurological disorder is indicated by increased abundance of said Protein Isoform(s) in the test sample relative to the abundance of said Protein Isoform(s) in the test sample from one or more persons free from neurological disorder, or with the previously determined reference range for that Protein Isoform in subjects free from neurological disorder. | 2009-12-17 |
20090311181 | Engineered Anti-Prostate Stem Cell Antigen (PSCA) Antibodies for Cancer Targeting - The invention provides novel humanized antibody fragments that specifically bind prostate cell-surface antigen (PSCA), a protein which is overexpressed in variety of cancers, including prostate, bladder, and pancreatic cancer. Methods are provided for the use of the compositions of the invention for the treatment of cancer, diagnosis of cancer, to provide a prognosis of cancer progression, and for cancer imaging. | 2009-12-17 |
20090311182 | Macromolecular Delivery Systems for Non-Invasive Imaging, Evaluation and Treatment of Arthritis and Other Inflammatory Diseases - This invention relates to biotechnology, more particularly, to water-soluble polymeric delivery systems for the imaging, evaluation and/or treatment of rheumatoid arthritis and other inflammatory diseases. Using modern MR imaging techniques, the specific accumulation of macromolecules in arthritic joints in adjuvant-induced arthritis in rats is demonstrated. The strong correlation between the uptake and retention of the MR contrast agent labeled polymer with histopathological features of inflammation and local tissue damage demonstrates the practical applications of the macromolecular delivery system of the invention. | 2009-12-17 |
20090311183 | METALLOPROTEINASE 12 BINDING PROTEINS - Proteins that bind to matrix metalloproteinase 12 and methods of using such proteins are described. | 2009-12-17 |
20090311184 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE-RELATED COMPOUNDS - The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of peptides and peptide-related compounds, which are capable of crossing biological barriers with high penetration efficiency. The HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate. | 2009-12-17 |
20090311185 | Peptide having antianxiety activity and screening method therefor - The objects of the present invention are to provide a polypeptide having an antianxiety activity; a therapeutic agent containing the polypeptide; a method for treating anxiety using the polypeptide; a method of screening for a compound capable of activating or suppressing a receptor for the polypeptide and involved in the regulation of anxiety, a salt thereof, or a hydrate of them; and a kit for the screening. There is provided an antianxiety agent containing relaxin-3. | 2009-12-17 |
20090311186 | METHOD FOR CONTROLLING THE THERAPY OF PATIENTS SUFFERING FROM CARDIAC INSUFFICIENCY BY MEANS OF IN VITRO DETERMINATION OF THRESHOLD VALUES OF VASOACTIVE PEPTIDES - Disclosed is a method for controlling the therapeutic treatment of a patient suffering from cardiac insufficiency. In said method, it is determined how the concentration of at least one of the vasoactive peptides adrenomedullin (ADM), endothelin-1 (ET-1), and/or vasopressin (AVP) changes in the patient's blood after beginning the therapy, and the therapeutic measures are considered to be unsatisfactory and are modified in case said concentration does not decrease at all or not enough in relation to a threshold value for the respective vasoactive peptide. | 2009-12-17 |
20090311187 | Methods for predicting patient response to modulation of the Co-stimulatory pathway - The invention described herein relates to diagnostic and therapeutic methods and compositions useful for predicting the likelihood a patient will have favorable response to the administration of a pharmaceutically acceptable amount of an activator of the immune system (e.g, T-cells). | 2009-12-17 |
20090311188 | IN VIVO METHODS OF IDENTIFYING COMPOUNDS WHICH TARGET SUPPRESSED CANCER CELLS - In vitro and in vivo methods for identifying compounds capable of targeting suppressed cancer cells such as micrometastatic cells. The in vitro method includes the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix. The in vivo method includes a step of co-injecting labeled cancer cells with a malignant-phenotype suppressing matrix into a test animal to produce suppressed micrometastatic cells therein. | 2009-12-17 |
20090311189 | TEMPERATURE-JUMP DYNAMIC NUCLEAR POLARIZATION - In one aspect, the present invention provides a method for enhancing the sensitivity of liquid-state NMR or MRI experiments. In general, the method involves providing a frozen sample in a magnetic field, wherein the frozen sample includes a polarizing agent with at least one unpaired electron and an analyte with at least one spin half nucleus; polarizing the at least one spin half nucleus of the analyte by irradiating the frozen sample with radiation having a frequency that excites electron spin transitions in the at least one unpaired electron of the polarizing agent; melting the frozen sample to produce a molten sample; and (d) detecting nuclear spin transitions in the at least one spin half nucleus of the analyte in the molten sample. In certain embodiments, the methods further comprise a step of freezing a sample in a magnetic field to provide the frozen sample in a magnetic field. | 2009-12-17 |
20090311190 | SELF-ASSEMBLED, MICROPATTERNED, AND RADIO FREQUENCY (RF) SHIELDED BIOCONTAINERS AND THEIR USES FOR REMOTE SPATIALLY CONTROLLED CHEMICAL DELIVERY - The present invention relates to a nanoscale or microscale particle for encapsulation and delivery of materials or substances, including, but not limited to, cells, drugs, tissue, gels and polymers contained within the particle, with subsequent release of the therapeutic materials in situ, methods of fabricating the particle by folding a 2D precursor into the 3D particle, and the use of the particle in in-vivo or in-vitro applications The particle can be in any polyhedral shape and its surfaces can have either no perforations or nano/microscale perforations The particle is coated with a biocompatible metal, e g gold, or polymer e g parvlene, layer and the surfaces and hinges of the particle are made of any metal or polymer combinations. | 2009-12-17 |
20090311191 | IMAGING OF ATHEROSCLEROTIC PLAQUES USING LIPOSOMAL IMAGING AGENTS - Compositions and methods are disclosed for imaging atherosclerotic plaques. Example compositions comprise liposomes, the liposomes comprising: at least one first lipid or phospholipid; at least one second lipid or phospholipid which is derivatized with one or more polymers; and at least one sterically bulky excipient capable of stabilizing the liposomes. The liposomes encapsulate or associate a contrast enhancing agent. | 2009-12-17 |
20090311192 | CORE AND CORE-SHELL NANOPARTICLES CONTAINING IODINE FOR X-RAY IMAGING - Nanoparticles having an average particle size of less than 2000 nm, wherein said nanoparticles comprise a polymer having pendant cleavable iodine substituted groups are provided. Processes for preparing the nanoparticles and their use as a contrast agent for X-ray imaging are also described. | 2009-12-17 |
20090311193 | METHODS AND REAGENTS FOR IN VIVO IMAGING OF CANCER CELL LINES - Provided are reagents and methods for non-invasive in vivo imaging wherein the reagents comprise targeted carrier molecules conjugated to a NIR reporter molecule. In one aspect the targeted carrier molecule is an antibody, or fragment thereof that has specificity for an antigen in a living body, animal or human. In one embodiment the antibodies are anti-cancer/tumor marker antibodies, organ specific antibodies, tissue specific antibodies, cell type specific antibodies, cell surface specific antibodies, anti-viral antibodies, anti-bacterial antibodies and anti-pathogenic antibodies. The NIR reporter molecules are any fluorescent reporter molecule compatible with in vivo imaging and generally having an excitation wavelength of at least 580 nm. | 2009-12-17 |
20090311194 | METHODS AND COMPOSITIONS FOR THE PRODUCTION AND USE OF MAGNETOSOMES - Methods and compositions for using magnetosomes as cellular contrast agents and markers for magnetic resonance imaging are provided. Certain methods involve synthesizing magnetosomes in a cell as directed by a nucleotide construct comprising an exogenous polynucleotide sequence, wherein the magnetosome serves as a contrast agent or marker for magnetic resonance imaging. Methods of synthesizing and isolating magnetosomes for introduction into immune-matched cells within a tissue or subject for use as a contrast agent or marker for magnetic resonance imaging are also provided. Also provided are methods for stably transfecting cells to express a polypeptide that drives or modulates magnetosome production in the cell, cells produced by such methods and methods for their isolation, transgenic animals comprising at least one eukaryotic cell produced by such methods, and vectors and delivery systems for the transfection of such cells. Further provided are methods for non-invasively generating a visible image of a tissue or subject containing at least one cell such transfected cell, as well as use of such methods to monitor the location, migration, or proliferation of cells in a tissue or subject or to detect or monitor gene expression in a tissue or subject. | 2009-12-17 |
20090311195 | Compositions containing a solvated active agent suitable for dispensing as a compressed gas aerosol - A composition for solvating one or more active agents in an aqueous solution which is suitable for dispensing as a compressed gas aerosol composition is disclosed. The composition includes at least one surfactant, at least one active agent (such as a fragrance or an insecticide), and a compressed gas propellant. The at least one surfactant is preferably present in an amount from about 0.1 wt. % to about 3 wt. %. The at least one active agent is preferably present in an amount from about 0.1 wt. % to about 2 wt. %. The compressed gas propellant is preferably present in an amount from about 0.1 wt. % to about 1 wt. %. The total surfactant weight to active agent weight ratio for the composition is preferably about 1:3 to 5:1. The composition uses a reduced amount of surfactant and active agent thereby allowing for a more efficient active agent loading and a reduced stickiness or tackiness on surfaces contacted during use. | 2009-12-17 |
20090311196 | PHARMACEUTICAL AEROSOL COMPOSITION - Compositions which contain an active ingredient, a propellant containing a hydrofluoroalkane (HFA), a co-solvent, and a low-volatility component are useful for administering the active ingredient via an aerosol. | 2009-12-17 |
20090311197 | Method and Compositions for Oral Hygiene - The present invention comprises novel compositions and methods for oral hygiene and for treating and preventing oral disease in humans and in animals. In one embodiment, the novel compositions of the present invention comprise a unique oral hygiene solution that can be added to drinking water. The invention provides compositions and methods for maintaining oral health that are convenient to use and are formulated so that they are safe for regular use by humans and animals. | 2009-12-17 |
20090311198 | Perhydrolase for Tooth Whitening - The present invention provides compositions and methods for the use of perhydrolase to whiten teeth. | 2009-12-17 |
20090311199 | Use of Hydrogen Peroxide-Producing Bacteria for Tooth Whitening - The invention provides compositions and methods for whitening teeth of a subject comprising administering one or more isolated, non-pathogenic, hydrogen peroxide-producing bacterial strains to an oral cavity of a subject. | 2009-12-17 |
20090311200 | Oral Compositions and Uses Thereof - The present invention is directed to a dual phase mouth wash composition comprising a hydrophilic phase, a hydrophobic phase, and a hydrotrope, and methods of use thereof. The hydrophilic and hydrophobic phases remain separated and form a temporary emulsion when mixed. The emulsion spontaneously reverts back to the two original phases after rest, without the formation of a emulsion. | 2009-12-17 |
20090311201 | LIPOXIN ANALOGS AND METHODS FOR THE TREATMENT OF PERIODONTAL DISEASE - This invention provides new lipoxin analogs, compositions containing analogs, and methods of using these compounds and compositions for treating and preventing oral inflammation, including gingivitis, periodontitis, and other forms of periodontal disease. The invention also provides for methods of treating and preventing oral inflammation, including gingivitis, periodontitis, and other forms of periodontal disease with compositions containing COX-2 inhibitors. Further, the invention provides methods for preventing systemic diseases beyond theoral cavity that are related to periodontal disease using the composition containing lipoxin analogs, COX-2 inhibitors, or both. | 2009-12-17 |
20090311202 | COSMETIC PREPARATION FOR EXTENSION TANNING - The invention relates to a cosmetic preparation for tan extension. The cosmetic includes as active ingredient a complex of 0.1 to 3.0 wt.-% caffeine, 0.2 to 2 wt.-% Phototan®, 0.01 to 1.0 wt.-% copper gluconate and further cosmetic auxiliaries, excipients, further active substances and mixtures thereof to make 100 wt.-%. It is possible to achieve a sun tan extension of up to 7 to 9 days, and in some cases up to 11 days. | 2009-12-17 |
20090311203 | GEM-DIFLUORIDE C-GLYCOPEPTIDE COMPOUNDS, THEIR PREPARATION AND USE PARTICULARLY FOR PRESERVATION OF BIOLOGICAL MATERIALS - The invention relates to a gem-difluoride C-glycopeptide compound with formula I where n is an integer equal to 3 or 4, R represents a hydrogen atom, an alkyl, benzyl, acetyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl group, R′ represents OR, NR′R″, N | 2009-12-17 |
20090311204 | CAROTENOID COMPOSITIONS USEFUL FOR WHITENING SKIN - The present invention relates to use of carotenoid preparations for promoting skin whitening. Particularly, the present invention discloses that a combination of phytoene and phytofluene is effective in whitening skin. The present invention further relates to carotenoid compositions comprising a combination of phytofluene and phytofluene effective in whitening skin and at least one additional carotenoid, particularly carotenoids devoid of highly intense color. | 2009-12-17 |
20090311205 | Co-Polymers in Hair Styling Applications - Hair is treated with a copolymer of an unsaturated ester and a styrene sulphonate monomer to reducing damage to hair caused by subsequent heat treatment. The styrene sulphonate monomer is desirably sodium styrene sulphonate and the unsaturated ester is desirably of an unsaturated monocarboxylic acid, such as (meth)acrylic acid, or dicarboxylic acid, such as maleic acid, and an alcohol, desirably an alkoxylated alcohol such as ethoxylated lanolin alcohol. Formulations for hair treatment generally include from about 0.5 to about 25% by weight of the copolymer. | 2009-12-17 |
20090311206 | COOLING COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING (1R,2S,5R)-2-ISOPROPYL-5-METHYL-N-(2-(PYRIDIN-2-YL)ETHYL)-CYCLOHEXANE CARBOXAMIDE AND/OR (1R,2S,5R)-N-(4-CYANOMETHYL-PHENYL)-2-ISOPROPYL-5-METHYLCYCLOHEXANE CARBOXAMIDE FOR REDUCING SKIN REDDENING - A topical cosmetic and dermatological preparation for reducing skin reddening which comprises (1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1R,2S,5R)—N-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide. | 2009-12-17 |
20090311207 | ENHANCED PHOTOCONDUCTIVITY AND SPF OF SEMICONDUCTORS - The present disclosure provides a way to enhance the photoconductivity and/or the SPF of a semiconductor. By dispersing the semiconductor with a compound having multiple phenyl groups in a polar carrier oil, the semiconductor exhibits greatly improved photoconductivity and/or SPF over dispersions comprising the semiconductor alone. | 2009-12-17 |
20090311208 | Oil In Silicone Emulsions and Compositions Containing Same - The present invention provides an oil in silicone emulsion and an oil in silicone/water in silicone dual emulsion. These emulsions employ a silicone resin as the emulsifying agent, include an effective amount of one or more active ingredients, such as, a sunscreen and/or insect repellent and provide enhanced aesthetics and SPF. Also provided are methods of preparation of the oil in silicone and the oil in silicone/water in silicone dual emulsions, compositions that employ the emulsions and methods of using the compositions to repel insects from skin and protect skin from exposure to the sun. | 2009-12-17 |
20090311209 | Interference Pigments on the Basis of Glass Flakes - The present invention relates to pigments, comprising a plate-like substrate of glass having an average thickness of <1 μm, especially of from 20 nm to 400 nm, and (a) a dielectric material, especially a metal oxide, having a high index of refraction; or (a) a metal layer, especially a thin semi-transparent metal layer; a process for their production and their use in paints, ink-jet printing, for dyeing textiles, for pigmenting coatings (paints), printing inks, plastics, cosmetics, glazes for ceramics and glass. | 2009-12-17 |
20090311210 | CONDITIONING AGENT AND A METHOD FOR MAKING HAIR HAVING A SHAPE MEMORY EFFECT - A method of imparting a shape memory effect to hair may include administrating an effective amount of a hair-conditioning agent to hair. The hair-conditioning agent may include a shape memory polymer selected from the group consisting of a polyurethane, an acrylic acid copolymer, a pyridine-based copolymer, and a pyrrolidone copolymer. | 2009-12-17 |
20090311211 | Aqueous Dispersions Of Polyorganosiloxanes Containing Urea Groups - Polyorganosiloxanes containing urea groups can be obtained in the form of aqueous dispersions by firstly dissolving them in an organic solvent, then dispersing this solution with water with co-use of auxiliaries, subjecting the mixture to homogenization and then at least partially removing the organic solvent. The aqueous dispersions prepared in this way are suitable as additive for detergents, fabric softeners, haircare compositions, shampoos and for textile finishing. | 2009-12-17 |
20090311212 | Agent for Forming Double Eyelid - An agent for forming double eyelid is provided, which contains rubber latex, synthetic resin emulsion and alkanolamine therein. In such agent, those three component elements are admixed with one another, such that the mixing ratios (wt. %) respectively thereof fall within a polygonal region defined in ternary composition diagram shown in FIG. | 2009-12-17 |
20090311213 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETINOID-RESPONSIVE CONDITIONS - Methods and composition for treating a retinoid-responsive condition in a subject are provided according to embodiments of the present invention which include administering a therapeutically effective amount of a substance selected from the group consisting of: neutrophil gelatinase-associated lipocalin (NGAL), an NGAL analog, an NGAL stimulator and an analog of an NGAL stimulator, to a subject having a retinoid-responsive condition. Retinoid-responsive conditions illustratively include acne, rosacea, psoriasis, promyelocytic leukemia and neuroblastoma. | 2009-12-17 |
20090311214 | COMPOSITIONS AND METHODS FOR THE INNATE IMMUNE RESPONSE PATHWAY - Autoimmune diseases are the consequence of complex interactions between a mosaic of host genetic factors and etiologic elements. Celiac disease (CD) is an autoimmune disease prevalent in 1% of the general population, but is unique on two accounts; a) the majority (90%) of individuals with CD have the HLA class II DQ2 allele, the others HLA-DQ8 and b) the etiologic agent is gluten proteins from wheat and related prolamins in barley and rye. The disease process is generally considered to be mediated by T cells that recognize HLA-DQ2 specific peptide sequences in gluten. There is currently no therapeutic treatment for CD. To this end, the inventors have identified a novel therapeutic target for CD and innate immune pathways in other inflammatory conditions. | 2009-12-17 |
20090311215 | METHOD FOR TREATING CERVICAL CANCER - Use of Interleukin-20 for treating cervical cancer or cells infected with human papilloma virus. IL-20 can be administered alone or in conjunction with radiation or chemotherapeutic agents or surgical excision of the involved cells or lesions. | 2009-12-17 |
20090311216 | RECOMBINANT INTERFERON-BETA WITH ENHANCED BIOLOGICAL ACTIVITY - Human interferon-β protein analogs in which the asparagine at position 25, numbered in accordance with native human interferon-β, is recombinantly replaced with an aspartate residue exhibit a biological activity of human interferon-β (e.g. IFN-β 1b) at an increased level relative to IFN-β 1b. These analogs are obtained by introducing a gene coding for Asp25 IFN-β into a cell and expressing the recombinant protein. The resulting IFN-β protein analog is suitable for large scale manufacturing for incorporation in HA-containing or HA-free therapeutics for treatment of diseases including multiple sclerosis. A reduced Lys endoproteinase-C peptide map technique that produces a fingerprint profile for proteins using an enzymatic digest followed by RP-HPLC is also useful in quality control as an ID test for the IFN-β protein analog products. | 2009-12-17 |
20090311217 | 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES - The invention relates to 3-substituted-1H-indole compounds of the Formula I: | 2009-12-17 |
20090311218 | mutant interferon alpha protein and use thereof - The present invention has objects to provide a mutant interferon-α protein having a higher anti-viral and anti-tumor activity and to provide an agent for susceptive diseases, which contains the mutant interferon-α protein as an effective ingredient; and solves the above objects by providing a mutant protein which has an amino acid sequence of human interferon-α subtype α8 represented by any one of SEQ ID NOs:1 to 3, where the arginine residue at the 145 | 2009-12-17 |
20090311219 | Oncolytic Adenoviruses for Cancer Treatment - The invention relates to an oncolytic adenovirus for the treatment of cancer, containing a human DNA sequence isolating a promoter conferring selective expression on an adenoviral gene. Said adenovirus can also contain a sequence that optimizes the protein translation of an adenoviral gene regulated by a promoter conferring tumor selectivity. The invention is suitable for use in the treatment of cancer. | 2009-12-17 |